Genetics of Alzheimer's disease in Caribbean Hispanic and African American populations

Biological Psychiatry

Volumn 75, Issue 7, 2014, Pages 534-541

  Reitz, Christiane ^a,b   Mayeux, Richard ^a,b,c  

^a Taub Institute for Research on Alzheimer's Disease and the Aging Brain College of Physicians and Surgaons Columbia University ^*  (United States)

^b Vagelos College of Physicians and Surgeons   (United States)

^c Department of Medicine   (United States)

Author keywords

African American; Alzheimer's disease; Caribbean Hispanic; gene; genetics; minorities

Indexed keywords

AFRICAN AMERICAN; ALZHEIMER DISEASE; AMERICAN INDIAN; ENDOPHENOTYPE; EPIDEMIOLOGICAL DATA; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; HERITABILITY; HISPANIC; HUMAN; PRIORITY JOURNAL; REVIEW;

AFRICAN AMERICAN; ALZHEIMER'S DISEASE; CARIBBEAN HISPANIC; GENE; GENETICS; MINORITIES;

AFRICAN AMERICANS; ALZHEIMER DISEASE; APOLIPOPROTEINS E; CARIBBEAN REGION; GENOME-WIDE ASSOCIATION STUDY; HISPANIC AMERICANS; HUMANS; RISK FACTORS;

EID: 84896359655     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2013.06.003     Document Type: Review

References (100)

1. L. Fratiglioni, D. De Ronchi, and H. Aguero-Torres Worldwide prevalence and incidence of dementia Drugs Aging 15 1999 365 375
2. L.E. Hebert, J. Weuve, P.A. Scherr, and D.A. Evans Alzheimer disease in the United States (2010-2050) estimated using the 2010 census Neurology 80 2013 1778 1783
3. A. Goate Segregation of a missense mutation in the amyloid beta-protein precursor gene with familial Alzheimer's disease J Alzheimers Dis 9 suppl 3 2006 341 347
4. A. Goate, M.C. Chartier-Harlin, M. Mullan, J. Brown, F. Crawford, and L. Fidani et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease Nature 349 1991 704 706
5. R. Sherrington, E.I. Rogaev, Y. Liang, E.A. Rogaeva, G. Levesque, and M. Ikeda et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease Nature 375 1995 754 760
6. E. Levy-Lahad, W. Wasco, P. Poorkaj, D.M. Romano, J. Oshima, and W.H. Pettingell et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus Science 269 1995 973 977
7. A.J. Slooter, M. Cruts, S. Kalmijn, A. Hofman, M.M. Breteler, and C. Van Broeckhoven et al. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: The Rotterdam Study Arch Neurol 55 1998 964 968
8. L.A. Farrer, L.A. Cupples, J.L. Haines, B. Hyman, W.A. Kukull, and R. Mayeux et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium JAMA 278 1997 1349 1356
9. A. Ward, S. Crean, C.J. Mercaldi, J.M. Collins, D. Boyd, and M.N. Cook et al. Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer's disease: A systematic review and meta-analysis Neuroepidemiology 38 2012 1 17
10. J.C. Lambert, S. Heath, G. Even, D. Campion, K. Sleegers, and M. Hiltunen et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease Nat Genet 41 2009 1094 1099
11. P. Hollingworth, D. Harold, R. Sims, A. Gerrish, J.C. Lambert, and M.M. Carrasquillo et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease Nat Genet 43 2011 429 435
12. S. Seshadri, A.L. Fitzpatrick, M.A. Ikram, A.L. DeStefano, V. Gudnason, and M. Boada et al. Genome-wide analysis of genetic loci associated with Alzheimer disease JAMA 303 2010 1832 1840
13. A.C. Naj, G. Jun, G.W. Beecham, L.S. Wang, B.N. Vardarajan, and J. Buros et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease Nat Genet 43 2011 436 441
14. C. Reitz, S. Tokuhiro, L.N. Clark, C. Conrad, J.P. Vonsattel, and L.N. Hazrati et al. SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimer's disease risk Ann Neurol 69 2011 47 64
15. R. Guerreiro, A. Wojtas, J. Bras, M. Carrasquillo, E. Rogaeva, and E. Majounie et al. TREM2 variants in Alzheimer's disease N Engl J Med 368 2013 117 127
16. T. Jonsson, H. Stefansson, S. Steinberg, I. Jonsdottir, P.V. Jonsson, and J. Snaedal et al. Variant of TREM2 associated with the risk of Alzheimer's disease N Engl J Med 368 2013 107 116
17. M. Gatz, N.L. Pedersen, S. Berg, B. Johansson, K. Johansson, and J.A. Mortimer et al. Heritability for Alzheimer's disease: The study of dementia in Swedish twins J Gerontol A Biol Sci Med Sci 52 1997 M117 M125
18. D.A. Evans, D.A. Bennett, R.S. Wilson, J.L. Bienias, M.C. Morris, and P.A. Scherr et al. Incidence of Alzheimer disease in a biracial urban community: Relation to apolipoprotein E allele status Arch Neurol 60 2003 185 189
19. N.R. Graff-Radford, R.C. Green, R.C. Go, M.L. Hutton, T. Edeki, and D. Bachman et al. Association between apolipoprotein E genotype and Alzheimer disease in African American subjects Arch Neurol 59 2002 594 600
20. J.R. Murrell, B. Price, K.A. Lane, O. Baiyewu, O. Gureje, and A. Ogunniyi et al. Association of apolipoprotein E genotype and Alzheimer disease in African Americans Arch Neurol 63 2006 431 434
21. M.X. Tang, P. Cross, H. Andrews, D.M. Jacobs, S. Small, and K. Bell et al. Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan Neurology 56 2001 49 56
22. M.X. Tang, Y. Stern, K. Marder, K. Bell, B. Gurland, and R. Lantigua et al. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics JAMA 279 1998 751 755
23. (2012): 2012 Alzheimer's disease facts and figures Alzheimers Dement 8 2012 131 168
24. R.C. Green, L.A. Cupples, R. Go, K.S. Benke, T. Edeki, and P.A. Griffith et al. Risk of dementia among white and African American relatives of patients with Alzheimer disease JAMA 287 2002 329 336
25. J.C. Breitner, B.W. Wyse, J.C. Anthony, K.A. Welsh-Bohmer, D.C. Steffens, and M.C. Norton et al. APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study Neurology 53 1999 321 331
26. E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, and G.W. Small et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 1993 921 923
27. T. Gomez-Isla, H.L. West, G.W. Rebeck, S.D. Harr, J.H. Growdon, and J.J. Locascio et al. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease Ann Neurol 39 1996 62 70
28. C. Holmes, R. Levy, D.M. McLoughlin, J.F. Powell, and S. Lovestone Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease J Neurol Neurosurg Psychiatry 61 1996 580 583
29. B.T. Hyman, T. Gomez-Isla, G.W. Rebeck, M. Briggs, H. Chung, and H.L. West et al. Epidemiological, clinical, and neuropathological study of apolipoprotein E genotype in Alzheimer's disease Ann N Y Acad Sci 802 1996 1 5
30. A. Kurz, K. Altland, N. Lautenschlager, R. Zimmer, R. Busch, and I. Gerundt et al. Apolipoprotein E type 4 allele and Alzheimer's disease: Effect on age at onset and relative risk in different age groups J Neurol 243 1996 452 456
31. D.L. Murman, N.L. Foster, S.P. Kilgore, C.A. McDonagh, and J.K. Fink Apolipoprotein E and Alzheimer's disease: Strength of association is related to age at onset Dementia 7 1996 251 255
32. J. Poirier, J. Davignon, D. Bouthillier, S. Kogan, P. Bertrand, and S. Gauthier Apolipoprotein E polymorphism and Alzheimer's disease Lancet 342 1993 697 699
33. A.D. Roses Alzheimer's disease: the genetics of risk Hosp Pract (Minneap) 32 1997 51-55, 58-63, 67-59
34. M.X. Tang, G. Maestre, W.Y. Tsai, X.H. Liu, L. Feng, and W.Y. Chung et al. Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City Am J Hum Genet 58 1996 574 584
35. J.W. Ashford, and J.A. Mortimer Non-familial Alzheimer's disease is mainly due to genetic factors J Alzheimers Dis 4 2002 169 177
36. W.J. Strittmatter, K.H. Weisgraber, D.Y. Huang, L.M. Dong, G.S. Salvesen, and M. Pericak-Vance et al. Binding of human apolipoprotein E to synthetic amyloid beta peptide: Isoform-specific effects and implications for late-onset Alzheimer disease Proc Natl Acad Sci U S A 90 1993 8098 8102
37. D.E. Schmechel, A.M. Saunders, W.J. Strittmatter, B.J. Crain, C.M. Hulette, and S.H. Joo et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease Proc Natl Acad Sci U S A 90 1993 9649 9653
38. G.W. Rebeck, J.S. Reiter, D.K. Strickland, and B.T. Hyman Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions Neuron 11 1993 575 580
39. K.R. Bales, T. Verina, D.J. Cummins, Y. Du, R.C. Dodel, and J. Saura et al. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease Proc Natl Acad Sci U S A 96 1999 15233 15238
40. K.R. Bales, T. Verina, R.C. Dodel, Y. Du, L. Altstiel, and M. Bender et al. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition Nat Genet 17 1997 263 264
41. M.S. Kindy, and D.J. Rader Reduction in amyloid A amyloid formation in apolipoprotein-E-deficient mice Am J Pathol 152 1998 1387 1395
42. J. Ma, A. Yee, H.B. Brewer Jr, S. Das, and H. Potter Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments Nature 372 1994 92 94
43. D.A. Sanan, K.H. Weisgraber, S.J. Russell, R.W. Mahley, D. Huang, and A. Saunders et al. Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3 J Clin Invest 94 1994 860 869
44. D.M. Holtzman, K.R. Bales, T. Tenkova, A.M. Fagan, M. Parsadanian, and L.J. Sartorius et al. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease Proc Natl Acad Sci U S A 97 2000 2892 2897
45. D.M. Holtzman, K.R. Bales, S. Wu, P. Bhat, M. Parsadanian, and A.M. Fagan et al. Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease J Clin Invest 103 1999 R15 R21
46. D.L. Sparks, S.W. Scheff, J.C. Hunsaker 3rd, H. Liu, T. Landers, and D.R. Gross Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol Exp Neurol 126 1994 88 94
47. L.M. Refolo, B. Malester, J. LaFrancois, T. Bryant-Thomas, R. Wang, and G.S. Tint et al. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model Neurobiol Dis 7 2000 321 331
48. S. Bodovitz, and W.L. Klein Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein J Biol Chem 271 1996 4436 4440
49. D.S. Howland, S.P. Trusko, M.J. Savage, A.G. Reaume, D.M. Lang, and J.D. Hirsch et al. Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol J Biol Chem 273 1998 16576 16582
50. B. Tycko, J.H. Lee, A. Ciappa, A. Saxena, C.M. Li, and L. Feng et al. APOE and APOC1 promoter polymorphisms and the risk of Alzheimer disease in African American and Caribbean Hispanic individuals Arch Neurol 61 2004 1434 1439
51. C. Reitz, G. Jun, A. Naj, R. Rajbhandary, B.N. Vardarajan, and L.S. Wang et al. Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E 4,and the risk of late-onset Alzheimer disease in African Americans JAMA 309 2013 1483 1492
52. A.D. Roses, M.W. Lutz, H. Amrine-Madsen, A.M. Saunders, D.G. Crenshaw, and S.S. Sundseth et al. A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease Pharmacogenomics J 10 2010 375 384
53. C. Cruchaga, P. Nowotny, J.S. Kauwe, P.G. Ridge, K. Mayo, and S. Bertelsen et al. Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease Arch Neurol 68 2011 1013 1019
54. G. Jun, B.N. Vardarajan, J. Buros, C.E. Yu, M.V. Hawk, and B.A. Dombroski et al. Comprehensive search for Alzheimer disease susceptibility loci in the APOE region Arch Neurol 69 2012 1270 1279
55. M.A. Pericak-Vance, M.P. Bass, L.H. Yamaoka, P.C. Gaskell, W.K. Scott, and H.A. Terwedow et al. Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12 JAMA 278 1997 1237 1241
56. E. Rogaeva, S. Premkumar, Y. Song, S. Sorbi, N. Brindle, and A. Paterson et al. Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity JAMA 280 1998 614 618
57. W.K. Scott, J.M. Grubber, P.M. Conneally, G.W. Small, C.M. Hulette, and C.K. Rosenberg et al. Fine mapping of the chromosome 12 late-onset Alzheimer disease locus: Potential genetic and phenotypic heterogeneity Am J Hum Genet 66 2000 922 932
58. W.K. Scott, J.M. Grubber, S.M. Abou-Donia, T.D. Church, A.M. Saunders, and A.D. Roses et al. Further evidence linking late-onset Alzheimer disease with chromosome 12 JAMA 281 1999 513 514
59. R. Mayeux, J.H. Lee, S.N. Romas, D. Mayo, V. Santana, and J. Williamson et al. Chromosome-12 mapping of late-onset Alzheimer disease among Caribbean Hispanics Am J Hum Genet 70 2002 237 243
60. J.H. Lee, R. Mayeux, D. Mayo, J. Mo, V. Santana, and J. Williamson et al. Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics Mol Psychiatry 9 2004 1042 1051
61. J.H. Lee, R. Cheng, E. Rogaeva, Y. Meng, Y. Stern, and V. Santana et al. Further examination of the candidate genes in chromosome 12p13 locus for late-onset Alzheimer disease Neurogenetics 9 2008 127 138
62. J.H. Lee, R. Cheng, V. Santana, J. Williamson, R. Lantigua, and M. Medrano et al. Expanded genomewide scan implicates a novel locus at 3q28 among Caribbean hispanics with familial Alzheimer disease Arch Neurol 63 2006 1591 1598
63. D.W. Hahs, J.L. McCauley, A.E. Crunk, L.L. McFarland, P.C. Gaskell, and L. Jiang et al. A genome-wide linkage analysis of dementia in the Amish Am J Med Genet B Neuropsychiatr Genet 141B 2006 160 166
64. M. Hiltunen, A. Mannermaa, D. Thompson, D. Easton, M. Pirskanen, and S. Helisalmi et al. Genome-wide linkage disequilibrium mapping of late-onset Alzheimer's disease in Finland Neurology 57 2001 1663 1668
65. P. Kehoe, F. Wavrant-De Vrieze, R. Crook, W.S. Wu, P. Holmans, and I. Fenton et al. A full genome scan for late onset Alzheimer's disease Hum Mol Genet 8 1999 237 245
66. M.A. Pericak-Vance, J. Grubber, L.R. Bailey, D. Hedges, S. West, and L. Santoro et al. Identification of novel genes in late-onset Alzheimer's disease Exp Gerontol 35 2000 1343 1352
67. W.S. Wu, P. Holmans, F. Wavrant-DeVrieze, S. Shears, P. Kehoe, and R. Crook et al. Genetic studies on chromosome 12 in late-onset Alzheimer disease JAMA 280 1998 619 622
68. A. Myers, P. Holmans, H. Marshall, J. Kwon, D. Meyer, and D. Ramic et al. Susceptibility locus for Alzheimer's disease on chromosome 10 Science 290 2000 2304 2305
69. N. Ertekin-Taner, N. Graff-Radford, L.H. Younkin, C. Eckman, M. Baker, and J. Adamson et al. Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees Science 290 2000 2303 2304
70. L. Bertram, D. Blacker, K. Mullin, D. Keeney, J. Jones, and S. Basu et al. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q Science 290 2000 2302 2303
71. S.R. Hughes, O. Khorkova, S. Goyal, J. Knaeblein, J. Heroux, and N.G. Riedel et al. Alpha2-macroglobulin associates with beta-amyloid peptide and prevents fibril formation Proc Natl Acad Sci U S A 95 1998 3275 3280
72. B. Johnson, V. Santana, N. Schupf, M.X. Tang, Y. Stern, and R. Mayeux et al. The heritability of abstract reasoning in Caribbean Latinos with familial Alzheimer disease Dement Geriatr Cogn Disord 24 2007 411 417
73. J.H. Lee, A. Flaquer, Y. Stern, B. Tycko, and R. Mayeux Genetic influences on memory performance in familial Alzheimer disease Neurology 62 2004 414 421
74. J.H. Lee, R. Cheng, N. Schupf, J. Manly, R. Lantigua, and Y. Stern et al. The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort Arch Neurol 64 2007 501 506
75. E. Rogaeva, Y. Meng, J.H. Lee, Y. Gu, T. Kawarai, and F. Zou et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease Nat Genet 39 2007 168 177
76. C. Reitz, R. Cheng, E. Rogaeva, J.H. Lee, S. Tokuhiro, and F. Zou et al. Meta-analysis of the association between variants in SORL1 and Alzheimer disease Arch Neurol 68 2011 99 106
77. J.H. Lee, R. Cheng, S. Barral, C. Reitz, M. Medrano, and R. Lantigua et al. Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals Arch Neurol 68 2011 320 328
78. C. Reitz, G. Tosto, R. Mayeux, and J.A. Luchsinger Genetic variants in the Fat and Obesity Associated (FTO) gene and risk of Alzheimer's disease PLoS One 7 2012 e50354
79. C. Dina, D. Meyre, S. Gallina, E. Durand, A. Korner, and P. Jacobson et al. Variation in FTO contributes to childhood obesity and severe adult obesity Nat Genet 39 2007 724 726
80. J.K. Hertel, S. Johansson, E. Sonestedt, A. Jonsson, R.T. Lie, and C.G. Platou et al. FTO, type 2 diabetes, and weight gain throughout adult life: A meta-analysis of 41,504 subjects from the Scandinavian HUNT, MDC, and MPP studies Diabetes 60 2011 1637 1644
81. K. Wang, W.D. Li, C.K. Zhang, Z. Wang, J.T. Glessner, and S.F. Grant et al. A genome-wide association study on obesity and obesity-related traits PLoS One 6 2011 e18939
82. A.J. Ho, J.L. Stein, X. Hua, S. Lee, D.P. Hibar, and A.D. Leow et al. A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly Proc Natl Acad Sci U S A 107 2010 8404 8409
83. C. Reitz, C. Conrad, K. Roszkowski, R.S. Rogers, and R. Mayeux Effect of genetic variation in LRRTM3 on risk of Alzheimer disease Arch Neurol 69 2012 894 900
84. M. Ghani, D. Pinto, J.H. Lee, Y. Grinberg, C. Sato, and D. Moreno et al. Genome-wide survey of large rare copy number variants in Alzheimer's disease among Caribbean hispanics G3 (Bethesda) 2 2012 71 78
85. C. Reitz, R. Cheng, N. Schupf, J.H. Lee, P.D. Mehta, and E. Rogaeva et al. Association between variants in IDE-KIF11-HHEX and plasma amyloid beta levels Neurobiol Aging 33 199 2012 e113 197
86. J.A. Prince, L. Feuk, H.F. Gu, B. Johansson, M. Gatz, and K. Blennow et al. Genetic variation in a haplotype block spanning IDE influences Alzheimer disease Hum Mutat 22 2003 363 371
87. N. Ertekin-Taner, M. Allen, D. Fadale, L. Scanlin, L. Younkin, and R.C. Petersen et al. Genetic variants in a haplotype block spanning IDE are significantly associated with plasma Abeta42 levels and risk for Alzheimer disease Hum Mutat 23 2004 334 342
88. A. Perez, L. Morelli, J.C. Cresto, and E.M. Castano Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains Neurochem Res 25 2000 247 255
89. W. Farris, S. Mansourian, Y. Chang, L. Lindsley, E.A. Eckman, and M.P. Frosch et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo Proc Natl Acad Sci U S A 100 2003 4162 4167
90. N. Rudovich, O. Pivovarova, E. Fisher, A. Fischer-Rosinsky, J. Spranger, and M. Mohlig et al. Polymorphisms within insulin-degrading enzyme (IDE) gene determine insulin metabolism and risk of type 2 diabetes J Mol Med (Berl) 87 2009 1145 1151
91. E.S. Athan, J. Williamson, A. Ciappa, V. Santana, S.N. Romas, and J.H. Lee et al. A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families JAMA 286 2001 2257 2263
92. A.M. Bertoli Avella, B. Marcheco Teruel, J.J. Llibre Rodriguez, N. Gomez Viera, I. Borrajero Martinez, and E.A. Severijnen et al. A novel presenilin 1 mutation (L174 M) in a large Cuban family with early onset Alzheimer disease Neurogenetics 4 2002 97 104
93. M.W. Logue, M. Schu, B.N. Vardarajan, J. Buros, R.C. Green, and R.C. Go et al. A comprehensive genetic association study of Alzheimer disease in African Americans Arch Neurol 68 2011 1569 1579
94. J.D. Burgess, O. Pedraza, N.R. Graff-Radford, M. Hirpa, F. Zou, and R. Miles et al. Association of common KIBRA variants with episodic memory and AD risk Neurobiol Aging 32 557 2011 e551 559
95. A. Papassotiropoulos, D.A. Stephan, M.J. Huentelman, F.J. Hoerndli, D.W. Craig, and J.V. Pearson et al. Common Kibra alleles are associated with human memory performance Science 314 2006 475 478
96. Akomolafe A, Lunetta KL, Erlich PM, Cupples LA, Baldwin CT, Huyck M, et al.; MIRAGE Study Group (2006): Genetic association between endothelial nitric oxide synthase and Alzheimer disease. Clin Genet 70:49-56
97. P.M. Erlich, K.L. Lunetta, L.A. Cupples, M. Huyck, R.C. Green, and C.T. Baldwin et al. Polymorphisms in the PON gene cluster are associated with Alzheimer disease Hum Mol Genet 15 2006 77 85
98. K.S. Benke, M.C. Carlson, B.Q. Doan, J.D. Walston, Q.L. Xue, and A.P. Reiner et al. The association of genetic variants in interleukin-1 genes with cognition: Findings from the cardiovascular health study Exp Gerontol 46 2011 1010 1019
99. K.T. Cuenco, R. Friedland, C.T. Baldwin, J. Guo, B. Vardarajan, and K.L. Lunetta et al. Association of TTR polymorphisms with hippocampal atrophy in Alzheimer disease families Neurobiol Aging 32 2011 249 256
100. S.A. Melville, J. Buros, A.R. Parrado, B. Vardarajan, M.W. Logue, and L. Shen et al. Multiple loci influencing hippocampal degeneration identified by genome scan Ann Neurol 72 2012 65 75